Seattle Genetics Inc (SGEN) Posts Mixed Q2 Results
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
EPS Growth %: +100.0%
Financial Fact:
Research and development: 92.71M
Today's EPS Names:
ANY, EAST, HSDT, More
EPS Growth %: +100.0%
Financial Fact:
Research and development: 92.71M
Today's EPS Names:
ANY, EAST, HSDT, More
Join SI Premium – FREE
Seattle Genetics Inc (NASDAQ: SGEN) reported Q2 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $10.97 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BuzzFeed (BZFD) Misses Q1 EPS by 53c, Revenue Misses; Offers Weak Q2 Guidance
- Centessa Pharmaceuticals plc (CNTA) Tops Q1 EPS by 4c
- Shimmick Corporation (SHIM) Misses Q1 EPS by $1.07, reaffirms guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
